PLEXXIKON
Plexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human disease. The company's products include PLX204 for the treatment of diabetes; PLX4032 for the treatment of melanoma and colorectal cancer; and PLX5568 kinase inhibitors for the treatment of pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease. It develops a portfolio of clinical and preclinical stage programs in various therapeutic areas,... including metabolic disease, such as obesity indications; oncology, such as osteolytic metastatic disease; and CNS, such as multiple sclerosis. The company’s portfolio of clinical and preclinical stage programs for other therapeutic areas include inflammation, such as systemic lupus erythematosus, inflammatory bowel disease, and osteoporosis; and cardiovascular, including hypertension and atherosclerosis.
PLEXXIKON
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.plexxikon.com
Total Employee:
51+
Status:
Closed
Contact:
(510)548-8014
Email Addresses:
[email protected]
Total Funding:
80.35 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail DigiCert SSL ATT
Similar Organizations
Adjuvax
Adjuvax specialises in the discovery and development of vaccination adjuvants.
Aviara Pharmaceuticals
Aviara Pharmaceuticals is the development of small molecule integrin inhibitors that modulate the activity.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
TorreyPines Therapeutics
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alta Partners
Alta Partners investment in Series B - Plexxikon
A. M. Pappas & Associates
A. M. Pappas & Associates investment in Series B - Plexxikon
NIF Ventures
NIF Ventures investment in Series B - Plexxikon
CW Ventures
CW Ventures investment in Series B - Plexxikon
Gimv
Gimv investment in Series B - Plexxikon
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Plexxikon
Walden International
Walden International investment in Series B - Plexxikon
More informations about "Plexxikon"
Plexxikon - Crunchbase Company Profile & Funding
Plexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human disease. The company's products include PLX204 for the treatment of diabetes; PLX4032 for the treatment of melanoma …See details»
Personalized Medicines | Zelboraf | Turalio | Plexxikon
Mar 31, 2022 Plexxikon Inc. has closed its office and research facility permanently as of March 31, 2022.. For more information about the closure, please refer to Daiichi Sankyo Company, …See details»
Plexxikon Company Profile | Management and Employees List
Plexxikon, a member of the Daiichi Sankyo Group since April 2011, is a leader in the structure-guided discovery and development of novel small molecule pharmaceuticals to treat human …See details»
Plexxikon Inc.: Contact Details and Business Profile
Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery …See details»
Plexxikon Company Profile 2024: Valuation, Investors
Plexxikon General Information Description. Manufacturer of small molecule pharmaceutical products designed to treat human disease. The company's products are used for the treatment of melanoma and colorectal cancer; and …See details»
Plexxikon Inc. - Berkeley, USA - bionity.com
Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery …See details»
Plexxikon Company Profile - Office Locations, Competitors ... - Craft
Plexxikon is a company engaged in the discovery and development of novel, small molecule pharmaceuticals. It offers products for the treatment of diabetes, melanoma and colorectal …See details»
Plexxikon - Company Profile - Tracxn
Nov 27, 2024 Plexxikon is a pharmaceutical company that develops small molecule pharmaceuticals in therapeutic areas like oncology, CNS and autoimmune. The company uses …See details»
Plexxikon Inc. - Company Profile & Staff Directory - ContactOut
Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery …See details»
Plexxikon - Overview, News & Similar companies | ZoomInfo.com
Jul 1, 2021 Who is Plexxikon. Plexxikon, a member of the Daiichi Sankyo Group since April 2011, is a leader in the structure-guided discovery and development of novel small mole cule …See details»
Plexxikon - Contacts, Employees, Board Members, Advisors & Alumni
Plexxikon has 2 board members and advisors, including Mike Carusi. Contacts. Edit Contacts Section. Job Department. Protected Content. Chief Executive Officer. Executive Management. …See details»
Plexxikon - Alchetron, The Free Social Encyclopedia
Nov 19, 2023 Plexxikon is an American drugdiscovery company based in Berkeley, California, that was cofounded in 2001 by Joseph Schlessinger of Yale University with SungHou Kim of …See details»
Plexxikon - Products, Competitors, Financials, Employees, …
Plexxikon is a drug discovery company that utilizes a structural proteomics approach to discover pharmaceuticals. Using high-throughput X-ray crystallography, the company screens for …See details»
Press Release - Daiichi Sankyo
Jan 12, 2022 Plexxikon, with approximately 60 employees, has been engaged in research and development in oncology and neurology since 2001, and as a part of Daiichi Sankyo since …See details»
Plexxikon - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 1, 2005: Series B - …See details»
Plexxikon, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Plexxikon, Inc. with its drug pipeline, therapeutic area, technology platform, 24 clinical trials, 35 news, and 218 literature, Disease Domain:Neoplasms, Hemic and Lymphatic …See details»
Plexxikon - Pappas Capital
Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals using its Scaffold-Based Drug Discovery Platform™. The company has built a robust and …See details»
Update: Daiichi Sankyo says Plexxikon R&D unit will close down
Dec 29, 2024 Plexxikon's targeted drugs have been modest sellers, with Zelboraf – sold by Roche – reaching a peak of just over $200 million in annual sales, below predictions of $700 …See details»
Plexxikon Inc. Company Profile | Basking Ridge, NJ | Competitors ...
Find company research, competitor information, contact details & financial data for Plexxikon Inc. of Basking Ridge, NJ. Get the latest business insights from Dun & Bradstreet.See details»